Your browser is no longer supported. Please, upgrade your browser.
Settings
XON Intrexon Corporation daily Stock Chart
XON [NYSE]
Intrexon Corporation
Index- P/E- EPS (ttm)-1.12 Insider Own0.10% Shs Outstand130.16M Perf Week-2.42%
Market Cap1.73B Forward P/E- EPS next Y-0.95 Insider Trans- Shs Float125.86M Perf Month-4.59%
Income-133.90M PEG- EPS next Q-0.32 Inst Own78.40% Short Float18.68% Perf Quarter7.44%
Sales200.20M P/S8.64 EPS this Y-107.90% Inst Trans3.51% Short Ratio13.59 Perf Half Y-26.29%
Book/sh4.43 P/B3.00 EPS next Y11.20% ROA-14.50% Target Price33.33 Perf Year-39.67%
Cash/sh0.84 P/C15.91 EPS next 5Y- ROE-24.60% 52W Range10.26 - 26.99 Perf YTD15.36%
Dividend- P/FCF- EPS past 5Y39.10% ROI-21.30% 52W High-50.76% Beta1.26
Dividend %- Quick Ratio1.80 Sales past 5Y87.80% Gross Margin69.00% 52W Low29.60% ATR0.84
Employees832 Current Ratio2.00 Sales Q/Q-6.10% Oper. Margin-72.00% RSI (14)52.77 Volatility4.75% 6.34%
OptionableYes Debt/Eq0.02 EPS Q/Q-34.50% Profit Margin-66.90% Rel Volume0.59 Prev Close12.77
ShortableYes LT Debt/Eq0.01 EarningsFeb 28 AMC Payout- Avg Volume1.73M Price13.29
Recom2.00 SMA200.89% SMA502.08% SMA200-26.03% Volume1,013,515 Change4.07%
Nov-10-17Reiterated Stifel Buy $57 → $39
Nov-10-17Reiterated Stifel Buy $39 → $57
Dec-29-16Initiated Northland Capital Outperform $40
May-03-16Initiated JMP Securities Mkt Outperform
Mar-01-16Reiterated Stifel Buy $69 → $57
Mar-01-16Reiterated Mizuho Neutral $28 → $29
Jan-25-16Reiterated Mizuho Neutral $42 → $28
Nov-11-15Upgrade Mizuho Underperform → Neutral $45 → $42
Oct-19-15Reiterated Wunderlich Buy $70 → $50
Oct-14-15Initiated BofA/Merrill Neutral $35
Sep-21-15Initiated Stifel Buy $69
Aug-11-15Downgrade Mizuho Neutral → Underperform $45
Aug-11-15Downgrade JP Morgan Overweight → Neutral
Jul-27-15Reiterated Wunderlich Buy $55 → $70
Jun-09-15Initiated Wunderlich Buy $55
Mar-10-15Downgrade Mizuho Buy → Neutral $14
Mar-03-15Reiterated Mizuho Buy $32 → $50
Jan-23-15Reiterated Mizuho Buy $30 → $32
Sep-03-13Initiated Mizuho Buy $30
Sep-03-13Initiated Barclays Equal Weight $25
Feb-22-18 08:00AM  Intrexon to Announce Fourth Quarter and Full Year 2017 Financial Results on March 1st PR Newswire
Feb-13-18 07:15AM  Ziopharm Oncology to Announce Fourth Quarter and Full Year 2017 Year-end Financial Results and Host Conference Call on March 1 GlobeNewswire
Feb-12-18 07:00AM  Ziopharm Oncology Presents Data on Very Rapid Production of CAR T Cells at Keystone Symposia Emerging Cellular Therapies: T Cells and Beyond GlobeNewswire
Feb-06-18 10:22AM  See the D.C.-area stocks hit hardest in the last week American City Business Journals +8.41%
08:55AM  Ziopharm Oncology Addresses Rumors and Stock Volatility, Affirms 2018 Guidance GlobeNewswire
Feb-01-18 08:20AM  Todays Research Reports on Trending Tickers: Incyte Corporation and Intrexon Corporation ACCESSWIRE
Jan-30-18 08:00AM  Fibrocell Announces FDA Allowance to Initiate Pediatric Enrollment in Phase 1/2 Clinical Trial of FCX-007 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB) GlobeNewswire -5.68%
Jan-29-18 05:39PM  First Eagle Fund of America 4th Quarter Commentary GuruFocus.com
09:57AM  Weekly CEO Buys Highlight GuruFocus.com
Jan-28-18 03:18PM  Better Buy: Intrexon Corporation vs. Celgene Motley Fool
Jan-19-18 04:34PM  Why IBM, GNC Holdings, and Intrexon Slumped Today Motley Fool
10:41AM  Intrexon Announces Closing of Public Offering of Common Stock and Exercise of Option by Underwriters PR Newswire
Jan-17-18 09:16AM  Intrexon Prices Public Offering of Common Stock PR Newswire
Jan-16-18 04:15PM  Intrexon Announces Proposed Public Offering of Common Stock PR Newswire -6.39%
Jan-12-18 09:20AM  AquaBounty Technologies, Inc. Announces $12 Million Underwritten Public Offering GlobeNewswire +11.27%
08:05AM  See what the IHS Markit Score report has to say about Intrexon Corp. Markit
Jan-10-18 08:05AM  See what the IHS Markit Score report has to say about Intrexon Corp. Markit
Jan-09-18 07:00AM  Ziopharm Oncology Provides Update on Standout Technologies during the 36th Annual J.P. Morgan Healthcare Conference GlobeNewswire +7.55%
Jan-04-18 08:35AM  Intrexon's ActoBio Therapeutics to Present at Biotech Showcase 2018 on January 8 PR Newswire -8.45%
08:30AM  Intrexon to Present at the 36th Annual J.P. Morgan Healthcare Conference PR Newswire
Jan-03-18 03:52PM  A Cash Infusion From the Boss Props Up Intrexon -- For Now Barrons.com
Jan-02-18 08:00AM  Intrexon Corporation Annual CEO Letter PR Newswire +16.93%
Dec-27-17 12:06PM  ETFs with exposure to Intrexon Corp. : December 27, 2017 Capital Cube
Dec-26-17 08:55AM  Intrexon Corp. :XON-US: Earnings Analysis: Q3, 2017 By the Numbers : December 26, 2017 Capital Cube
Dec-21-17 04:05PM  ZIOPHARM to Present at the 36th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-14-17 02:18PM  ETFs with exposure to Intrexon Corp. : December 14, 2017 Capital Cube -6.44%
Dec-06-17 08:43AM  Why Intrexon (XON) Could Be Positioned for a Slump Zacks
Nov-28-17 08:06AM  Intrexon Corporation (XON)s Earnings Grew 24.8%, Is It Enough? Simply Wall St.
08:04AM  See what the IHS Markit Score report has to say about Intrexon Corp. Markit
Nov-27-17 08:20AM  Report: Developing Opportunities within Social Reality, The Finish Line, Facebook, Organovo, Plug Power, and Intrexon Future Expectations, Projections Moving into 2018 GlobeNewswire
08:00AM  Intrexon Announces Key Management Appointments PR Newswire
Nov-26-17 07:21AM  Edited Transcript of XON earnings conference call or presentation 9-Nov-17 10:30pm GMT Thomson Reuters StreetEvents
Nov-22-17 08:03AM  See what the IHS Markit Score report has to say about Intrexon Corp. Markit +7.84%
Nov-20-17 07:00AM  ZIOPHARM Presents Positive Updated Results of Ad-RTS-hIL-12 Study in Brain Cancer at Society for Neuro-Oncology Annual Meeting GlobeNewswire
Nov-17-17 08:00AM  Todays Research Reports on Trending Tickers: Egalet Corporation and Intrexon Corporation ACCESSWIRE -5.65%
07:00AM  ZIOPHARM Oncology to Host Conference Call on November 20, 2017 at 10:15 a.m. ET to Discuss Updated Clinical Data Presented at the 2017 Annual Meeting of the Society for Neuro-Oncology GlobeNewswire
Nov-16-17 07:00AM  AquaBounty wins Gold Leaf Award for Best Emerging Agriculture Company from BIOTECanada GlobeNewswire +7.67%
05:54AM  Bill Miller, Kris Jenner share stocks they've got their eye on American City Business Journals
Nov-15-17 08:20AM  Todays Research Reports on Trending Tickers: Array BioPharma and Intrexon Corporation ACCESSWIRE
08:05AM  Here's What You Need to Know About Intrexon's Third-Quarter 2017 Earnings Motley Fool
07:30AM  Featured Company News - Zymeworks Enters Into License Agreement with Janssen Biotech to Develop and Commercialize Next Generation Bispecific Antibody Therapeutics ACCESSWIRE
Nov-14-17 08:55AM  Intrexon (XON) in Focus: Stock Moves 6.5% Higher Zacks
Nov-12-17 07:00PM  Is Peak Permian Only 3 Years Away? Oilprice.com
Nov-10-17 05:40PM  Why Intrexon Corporation Stock Got Crushed Today Motley Fool -25.63%
04:05PM  ZIOPHARM to Present at the Stifel 2017 Healthcare Conference GlobeNewswire
08:49AM  Intrexon (XON) Q3 Loss Narrower Than Expected, Revenues Miss Zacks
08:00AM  Intrexon to Present at the Stifel 2017 Healthcare Conference PR Newswire
Nov-09-17 04:05PM  Intrexon Announces Third Quarter 2017 Financial Results PR Newswire
03:00PM  Intrexon Corporation to Host Earnings Call ACCESSWIRE
08:35AM  Why Intrexon Corporation (XON) Could Be A Buy Simply Wall St.
Nov-08-17 08:16AM  Key Predictions for Q3 Earnings Reports of PBYI, XON, LGND Zacks
Nov-06-17 04:05PM  ZIOPHARM Oncology Reports Third Quarter 2017 Financial Results and Provides Update on Recent Activities GlobeNewswire
07:00AM  ZIOPHARM Announces Four Presentation Abstracts at the 2017 Annual Meeting of the Society for Neuro-Oncology GlobeNewswire
Nov-02-17 04:30PM  AquaBounty Technologies, Inc. Results for the quarter ended September 30, 2017 GlobeNewswire
Nov-01-17 09:37AM  ZIOPHARM Announces Five Abstracts Accepted for Presentation at the 2017 American Society of Hematology Annual Meeting GlobeNewswire
08:00AM  Intrexon to Announce Third Quarter 2017 Financial Results on November 9th PR Newswire
Oct-31-17 05:58PM  What's in Store for Intrexon (XON) This Earnings Season? Zacks
08:00AM  Today's Research Reports on Trending Tickers: Intrexon Corporation and Valeant Pharmaceuticals ACCESSWIRE
07:30AM  Agilis Biotherapeutics Announces Orphan Product Designation Approval in Europe for the Treatment of Friedreich Ataxia Business Wire
Oct-27-17 11:23AM  ETFs with exposure to Intrexon Corp. : October 27, 2017 Capital Cube
Oct-26-17 07:00AM  ZIOPHARM Oncology to Host Third-Quarter 2017 Financial Results and Corporate Update Conference Call on November 6, 2017 at 4:30 p.m. ET GlobeNewswire
Oct-23-17 09:02PM  Is This $13 Billion Food Security Crisis Intrexon's Next Big Opportunity? Motley Fool
08:00AM  Intrexon and Arch Pharmalabs Collaborate on Fermentative Production of an API to Replace Existing Process Sourced from Animals PR Newswire
Oct-19-17 08:00AM  Intrexon CEO to Participate in World Food Prize Leadership Panel on Global Hunger PR Newswire
Oct-17-17 03:49PM  Intrexon inks $100M funding deal with billionaire founder Randal Kirk American City Business Journals
Oct-16-17 04:13PM  Intrexon Corporation Enters into $100 Million Preferred Stock Equity Facility PR Newswire
08:00AM  Intrexon Crop Protection Achieves Milestone in Development of Pioneering Self-Limiting Fall Armyworm Solution PR Newswire
07:00AM  ZIOPHARM Oncology Announces First Patient Dosed in New Phase 1 Study of Ad-RTS-hIL-12 plus Veledimex for the Treatment of Pediatric Brain Tumors GlobeNewswire
Oct-12-17 07:00AM  ZIOPHARM Announces Three Presentations at the 2017 Annual Meeting of the Society for Neuro-Oncology GlobeNewswire
Oct-11-17 08:41AM  Oxitec do Brasil Receives Prestigious Award for Innovation and Impact PR Newswire
Oct-09-17 08:03AM  See what the IHS Markit Score report has to say about Intrexon Corp. Markit
Oct-06-17 08:19PM  Intrexon Corporation (XON): How Does It Impact Your Portfolio? Simply Wall St. -5.98%
11:11AM  ETFs with exposure to Intrexon Corp. : October 6, 2017 Capital Cube
11:05AM  Analysts Are Expecting Gas Fermentation to Be Huge for Intrexon. Here's Why They're Wrong. Motley Fool
Oct-05-17 08:09AM  Intrexon Corp. breached its 50 day moving average in a Bullish Manner : XON-US : October 5, 2017 Capital Cube
Oct-04-17 01:00PM  Transfer of Regulatory Jurisdiction for Oxitec's Self-limiting Friendly Aedes in the United States PR Newswire
Oct-03-17 08:03AM  See what the IHS Markit Score report has to say about Intrexon Corp. Markit
Oct-02-17 04:30PM  Fibrocell to Present at 2017 Cell & Gene Meeting on the Mesa GlobeNewswire
Oct-01-17 07:03AM  5 Incredible Synthetic Biology Holy Grails That Could Change the World Motley Fool
Sep-28-17 04:32PM  ZIOPHARM Oncology Appoints David Mauney, M.D., as Executive Vice President and Chief Business Officer GlobeNewswire
Sep-26-17 08:00AM  Fibrocell Reports Interim Results of Phase 1/2 Clinical Trial of FCX-007 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa GlobeNewswire
Sep-25-17 10:48AM  ETFs with exposure to Intrexon Corp. : September 25, 2017 Capital Cube
Sep-20-17 07:27AM  All You Need To Know About Intrexon Corporations (XON) Financial Health Simply Wall St.
Sep-19-17 11:00AM  Oxitec to Build State-of-the-Art Mosquito Egg Production Unit PR Newswire
Sep-18-17 08:00AM  ZIOPHARM Oncology Announces Updated Findings from Phase 1 Study of Ad-RTS-hIL-12 + Veledimex in Recurrent Glioblastoma Presented at American Academy of Neurological Surgery Annual Meeting GlobeNewswire
Sep-14-17 07:32PM  ETFs with exposure to Intrexon Corp. : September 14, 2017 Capital Cube
Sep-13-17 11:50AM  Intrexon Corp. :XON-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017 Capital Cube
11:00AM  Is Intrexon Corporation Stock Now a Bargain? Motley Fool
Sep-05-17 07:00AM  ZIOPHARM to Present at the Rodman & Renshaw 19th Annual Global Investment Conference GlobeNewswire
03:00AM  Oxitec's Innovative Solution to Tackle Growing Diamondback Moth Pest Issue Begins Field Trials PR Newswire
Sep-01-17 09:02AM  The Simple Reason I Won't Buy Intrexon Motley Fool
07:05AM  ZIOPHARM Oncology to Participate at Upcoming CAR-TCR Summit GlobeNewswire
Aug-31-17 04:01PM  Intrexon to Participate in Upcoming Investor Conferences PR Newswire
08:07AM  See what the IHS Markit Score report has to say about Intrexon Corp. Markit
Aug-30-17 08:02AM  See what the IHS Markit Score report has to say about Intrexon Corp. Markit
Aug-22-17 08:04AM  See what the IHS Markit Score report has to say about Intrexon Corp. Markit
Aug-21-17 01:43PM  Weekly CEO Buys Highlights GuruFocus.com
Aug-14-17 11:15AM  Intrexon Corp (XON) CEO Randal J Kirk Bought $2.5 million of Shares GuruFocus.com -5.60%
Aug-12-17 10:25PM  Edited Transcript of XON earnings conference call or presentation 9-Aug-17 9:30pm GMT Thomson Reuters StreetEvents
Aug-11-17 09:34AM  Intrexon Depended on 1 Customer for 58% of First-Half 2017 Revenue Growth Motley Fool +5.31%
Intrexon Corporation operates in the synthetic biology field in the United States. The company, through a suite of proprietary and complementary technologies, designs, builds, and regulates gene programs, which are DNA sequences that consist of key genetic components. Its technologies include UltraVector gene design and fabrication platform, and its associated library of modular DNA components; Cell Systems Informatics; RheoSwitch inducible gene switch; AttSite Recombinases; Protein Engineering; Laser-Enabled Analysis and Processing; and ActoBiotics platform. It also provides reproductive technologies and other genetic processes to cattle breeders and producers; genetic preservation and cloning technologies; genetically engineered swine for medical and genetic research; biological insect control solutions; technologies for non-browning apple without the use of any flavor-altering chemical or antioxidant additives; commercial aquaculture products; and artwork, children's toys, and novelty goods that are derived from living organisms or enabled by synthetic biology. The company serves health, food, energy, environment, and consumer sectors. Intrexon Corporation has collaboration and license agreements with Ares Trading S.A.; ZIOPHARM Oncology, Inc.; Oragenics, Inc.; Fibrocell Science, Inc.; Genopaver, LLC; S & I Ophthalmic, LLC; OvaXon, LLC; Intrexon Energy Partners, LLC; Persea Bio, LLC; Thrive Agrobiotics, Inc.; Intrexon Energy Partners II, LLC; Arch Pharmalabs Ltd.; and others. The company was formerly known as Genomatix Ltd. and changed its name to Intrexon Corporation in 2005. Intrexon Corporation was founded in 1998 and is based in Germantown, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ALVAREZ CESAR LDirectorFeb 20Option Exercise2.648,90623,512114,849Feb 22 04:51 PM
Frank StevenDirectorFeb 12Option Exercise2.648,90623,512189,093Feb 14 08:06 PM
KIRK RANDAL JChief Executive OfficerJan 19Buy12.501,000,00012,500,0007,782,622Jan 22 09:04 AM
KIRK RANDAL J10% OwnerDec 11Buy0.772,727,2732,100,0005,773,626Dec 13 05:28 PM
Last Andrew J.Chief Operating OfficerNov 13Buy12.102,00024,2004,000Nov 15 04:17 PM
Reed Thomas D.Chief Science OfficerOct 16Option Exercise2.6438,598101,899102,715Oct 17 04:59 PM
Gupta Vinita DDirectorAug 22Buy17.613,00052,8303,000Aug 23 04:37 PM
SHAPIRO ROBERT BDirectorAug 22Buy17.502,85049,88382,966Aug 23 04:34 PM
Last Andrew J.Chief Operating OfficerAug 14Buy19.992,00039,9802,000Aug 15 01:14 PM
KINDLER JEFFREY BDirectorAug 11Buy18.325,44099,66171,762Aug 15 01:15 PM
Nimrodi NirSVP-Corporate DevelopmentAug 11Buy18.753,36963,1697,369Aug 14 08:33 AM
Lehr Donald P.Chief Legal OfficerAug 11Buy18.331,09420,05328,249Aug 11 01:08 PM
Perez Jeffrey ThomasSVP, IP AffairsAug 11Buy17.891,00017,89012,537Aug 11 01:04 PM
MITCHELL DEAN JDirectorAug 11Buy18.335,00091,64018,103Aug 11 01:03 PM
KIRK RANDAL JChief Executive OfficerAug 11Buy18.85132,6252,499,9816,782,622Aug 14 08:57 AM
Sterling Rick L.Chief Financial OfficerJul 07Option Exercise2.6468,252180,18574,621Jul 10 08:32 AM
KIRK RANDAL J10% OwnerMay 08Sale2.5411,57629,40385,397May 08 05:30 PM
KIRK RANDAL J10% OwnerMay 05Sale2.7085,500230,85087,278May 08 05:30 PM
KIRK RANDAL J10% OwnerMay 04Sale3.7863,892241,629101,171May 08 05:30 PM